[안내] 항암제 STP1002 WHO에 Basroparib 국제일반명 등재 — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

ST PHARM News

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

ST PHARM News

Mar 23, 2023

[안내] 항암제 STP1002 WHO에 Basroparib 국제일반명 등재

- STP1002가 WHO에 Basroparib이라는 INN(International Nonproprietary Names, 국제일반명)으로 정식 등재되었습니다.